☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
mutated
Novartis' Capmatinib (INC280) Receives FDA's Priority Review for METex14 Mutated Advanced Non-Small Cell Lung Cancer
February 11, 2020
AstraZeneca Reports Updated Positive Results of Tagrisso (osimertinib) in P-III FLAURA Study for 1L EGFR-Mutated Non-Small Cell Lu...
August 9, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
